Phase I / II Study Of Carfilzomib (CFZ) Intensification Early After Autologous Transplantation (AHCT) For Plasma Cell Myeloma
Phase of Trial: Phase I/II
Latest Information Update: 03 Jun 2016
Price : $35 *
At a glance
- Drugs Carfilzomib (Primary) ; Filgrastim; Melphalan
- Indications Multiple myeloma
- Focus Therapeutic Use
- 28 May 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to discontinued.
- 31 Jan 2014 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 09 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.